TriSalus Life Sciences (TLSI) Interest Expenses (2020 - 2026)

TriSalus Life Sciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 18.78% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 102.51% increase from a year earlier, with the FY2025 full-year figure at $68.7 million, up 12.07% from the prior year.
• Interest Expenses declined to $1.4 million in Q1 2026 per TLSI's latest filing, from $3.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $3.0 million in Q4 2025 and bottomed at -$7000.0 in Q4 2024.
• The 5-year median for Interest Expenses is $439500.0 (2022), against an average of $767428.6.
• Across the five-year window, Interest Expenses sank 240.0% in 2024 and soared 43185.71% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $431000.0 in 2022, then sank by 98.84% to $5000.0 in 2023, then sank by 240.0% to -$7000.0 in 2024, then surged by 43185.71% to $3.0 million in 2025, then sank by 52.39% to $1.4 million in 2026.
• Per Business Quant, the three latest TLSI Interest Expenses figures stand at $1.4 million (Q1 2026), $3.0 million (Q4 2025), and $1.5 million (Q3 2025).